{"id":8205,"date":"2025-06-05T10:16:11","date_gmt":"2025-06-05T07:16:11","guid":{"rendered":"https:\/\/www.chemi-pharm.com\/?p=8205"},"modified":"2025-06-05T10:16:37","modified_gmt":"2025-06-05T07:16:37","slug":"e-veoselehe-liidestamise-toetusprogrammi-raames-voetakse-kasutusele-elektroonilised-veodokumendid","status":"publish","type":"post","link":"https:\/\/chemi-pharm.com\/et\/e-veoselehe-liidestamise-toetusprogrammi-raames-voetakse-kasutusele-elektroonilised-veodokumendid\/","title":{"rendered":"E-veoselehe\u00a0liidestamise\u00a0toetus-programmi raames v\u00f5etakse kasutusele elektroonilised veodokumendid"},"content":{"rendered":"\n

AS Chemi-Pharm v\u00f5tab e-veoselehe liidestamise toetusprogrammi raames kasutusele elektroonilised veodokumendid. Projekt viiakse ellu ajavahemikul 26.05.2025 – 30.09.2025.<\/p>\n\n\n\n

Euroopa Liidus hakkab 2027. aastal kehtima eFTI m\u00e4\u00e4rus, mis kohustab ettev\u00f5tteid kasutama elektroonilisi veodokumente. K\u00e4esoleva projekti elluviimisega tagab AS Chemi-Pharm eFTI m\u00e4\u00e4rusele vastavuse. Seejuures s\u00e4\u00e4stab e-veoselehe kasutuselev\u00f5tt ettev\u00f5ttes transpordi dokumentatsiooni koostamisele kuluvat aega, v\u00e4hendab vigu ning paberikulu ja sellega seotud CO\u2082 jalaj\u00e4lge.<\/p>\n\n\n\n

Projekti kogumaksumus on 10 200 eurot, millest Euroopa Liidu taasterahastu NextGenerationEU vahenditest kaetakse kuni 9 180 eurot.<\/p>\n\n\n\n

\"\"<\/figure>\n","protected":false},"excerpt":{"rendered":"AS Chemi-Pharm v\u00f5tab e-veoselehe liidestamise toetusprogrammi raames kasutusele elektroonilised veodokumendid. Projekt viiakse ellu ajavahemikul 26.05.2025 – 30.09.2025. Euroopa Liidus hakkab 2027. aastal kehtima eFTI m\u00e4\u00e4rus, mis kohustab ettev\u00f5tteid kasutama elektroonilisi veodokumente. K\u00e4esoleva projekti elluviimisega tagab AS Chemi-Pharm eFTI m\u00e4\u00e4rusele vastavuse. Seejuures s\u00e4\u00e4stab e-veoselehe kasutuselev\u00f5tt ettev\u00f5ttes transpordi dokumentatsiooni koostamisele kuluvat aega, v\u00e4hendab vigu ning paberikulu ja sellega seotud CO\u2082 jalaj\u00e4lge. Projekti kogumaksumus […]","protected":false},"author":13,"featured_media":7712,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_uag_custom_page_level_css":"","advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":"","ngg_post_thumbnail":0,"footnotes":""},"categories":[10],"tags":[48,49],"class_list":["post-8205","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uudised-est","tag-projekt-2","tag-nextgenerationeu-2"],"acf":[],"yoast_head":"\nE-veoselehe\u00a0liidestamise\u00a0toetus-programmi raames v\u00f5etakse kasutusele elektroonilised veodokumendid - Chemi-Pharm<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/chemi-pharm.com\/et\/e-veoselehe-liidestamise-toetusprogrammi-raames-voetakse-kasutusele-elektroonilised-veodokumendid\/\" \/>\n<meta property=\"og:locale\" content=\"et_EE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"E-veoselehe\u00a0liidestamise\u00a0toetus-programmi raames v\u00f5etakse kasutusele elektroonilised veodokumendid - Chemi-Pharm\" \/>\n<meta property=\"og:description\" content=\"AS Chemi-Pharm v\u00f5tab e-veoselehe liidestamise toetusprogrammi raames kasutusele elektroonilised veodokumendid. Projekt viiakse ellu ajavahemikul 26.05.2025 – 30.09.2025. Euroopa Liidus hakkab 2027. aastal kehtima eFTI m\u00e4\u00e4rus, mis kohustab ettev\u00f5tteid kasutama elektroonilisi veodokumente. K\u00e4esoleva projekti elluviimisega tagab AS Chemi-Pharm eFTI m\u00e4\u00e4rusele vastavuse. Seejuures s\u00e4\u00e4stab e-veoselehe kasutuselev\u00f5tt ettev\u00f5ttes transpordi dokumentatsiooni koostamisele kuluvat aega, v\u00e4hendab vigu ning paberikulu ja sellega seotud CO\u2082 jalaj\u00e4lge. Projekti kogumaksumus […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/chemi-pharm.com\/et\/e-veoselehe-liidestamise-toetusprogrammi-raames-voetakse-kasutusele-elektroonilised-veodokumendid\/\" \/>\n<meta property=\"og:site_name\" content=\"Chemi-Pharm\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/chemipharmeesti\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-05T07:16:11+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-05T07:16:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/chemi-pharm.com\/wp-content\/uploads\/2025\/01\/nextgen_rahastanud_el_nextgeneration_eng_hor_color.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"674\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Justin Hein\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/chemi-pharm.com\\\/et\\\/e-veoselehe-liidestamise-toetusprogrammi-raames-voetakse-kasutusele-elektroonilised-veodokumendid\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/chemi-pharm.com\\\/et\\\/e-veoselehe-liidestamise-toetusprogrammi-raames-voetakse-kasutusele-elektroonilised-veodokumendid\\\/\"},\"author\":{\"name\":\"Justin Hein\",\"@id\":\"https:\\\/\\\/chemi-pharm.com\\\/et\\\/#\\\/schema\\\/person\\\/edf286ff172528816261c5720fe3fc91\"},\"headline\":\"E-veoselehe\u00a0liidestamise\u00a0toetus-programmi raames v\u00f5etakse kasutusele elektroonilised veodokumendid\",\"datePublished\":\"2025-06-05T07:16:11+00:00\",\"dateModified\":\"2025-06-05T07:16:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/chemi-pharm.com\\\/et\\\/e-veoselehe-liidestamise-toetusprogrammi-raames-voetakse-kasutusele-elektroonilised-veodokumendid\\\/\"},\"wordCount\":96,\"publisher\":{\"@id\":\"https:\\\/\\\/chemi-pharm.com\\\/et\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/chemi-pharm.com\\\/et\\\/e-veoselehe-liidestamise-toetusprogrammi-raames-voetakse-kasutusele-elektroonilised-veodokumendid\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/chemi-pharm.com\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/nextgen_rahastanud_el_nextgeneration_eng_hor_color.jpg\",\"keywords\":[\"projekt\",\"nextgenerationeu\"],\"articleSection\":[\"Uudised eestikeelsed\"],\"inLanguage\":\"et\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/chemi-pharm.com\\\/et\\\/e-veoselehe-liidestamise-toetusprogrammi-raames-voetakse-kasutusele-elektroonilised-veodokumendid\\\/\",\"url\":\"https:\\\/\\\/chemi-pharm.com\\\/et\\\/e-veoselehe-liidestamise-toetusprogrammi-raames-voetakse-kasutusele-elektroonilised-veodokumendid\\\/\",\"name\":\"E-veoselehe\u00a0liidestamise\u00a0toetus-programmi raames v\u00f5etakse kasutusele elektroonilised veodokumendid - Chemi-Pharm\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/chemi-pharm.com\\\/et\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/chemi-pharm.com\\\/et\\\/e-veoselehe-liidestamise-toetusprogrammi-raames-voetakse-kasutusele-elektroonilised-veodokumendid\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/chemi-pharm.com\\\/et\\\/e-veoselehe-liidestamise-toetusprogrammi-raames-voetakse-kasutusele-elektroonilised-veodokumendid\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/chemi-pharm.com\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/nextgen_rahastanud_el_nextgeneration_eng_hor_color.jpg\",\"datePublished\":\"2025-06-05T07:16:11+00:00\",\"dateModified\":\"2025-06-05T07:16:37+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/chemi-pharm.com\\\/et\\\/e-veoselehe-liidestamise-toetusprogrammi-raames-voetakse-kasutusele-elektroonilised-veodokumendid\\\/#breadcrumb\"},\"inLanguage\":\"et\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/chemi-pharm.com\\\/et\\\/e-veoselehe-liidestamise-toetusprogrammi-raames-voetakse-kasutusele-elektroonilised-veodokumendid\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"et\",\"@id\":\"https:\\\/\\\/chemi-pharm.com\\\/et\\\/e-veoselehe-liidestamise-toetusprogrammi-raames-voetakse-kasutusele-elektroonilised-veodokumendid\\\/#primaryimage\",\"url\":\"https:\\\/\\\/chemi-pharm.com\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/nextgen_rahastanud_el_nextgeneration_eng_hor_color.jpg\",\"contentUrl\":\"https:\\\/\\\/chemi-pharm.com\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/nextgen_rahastanud_el_nextgeneration_eng_hor_color.jpg\",\"width\":1200,\"height\":674},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/chemi-pharm.com\\\/et\\\/e-veoselehe-liidestamise-toetusprogrammi-raames-voetakse-kasutusele-elektroonilised-veodokumendid\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/chemi-pharm.com\\\/et\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"E-veoselehe\u00a0liidestamise\u00a0toetus-programmi raames v\u00f5etakse kasutusele elektroonilised veodokumendid\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/chemi-pharm.com\\\/et\\\/#website\",\"url\":\"https:\\\/\\\/chemi-pharm.com\\\/et\\\/\",\"name\":\"Chemi-Pharm\",\"description\":\"Chemi-Pharm'i professionaalsed ja k\u00f5rge kvaliteediga desinfektsiooni- ja puhastusvahendid otse tootjalt\",\"publisher\":{\"@id\":\"https:\\\/\\\/chemi-pharm.com\\\/et\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/chemi-pharm.com\\\/et\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"et\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/chemi-pharm.com\\\/et\\\/#organization\",\"name\":\"Chemi-Pharm\",\"url\":\"https:\\\/\\\/chemi-pharm.com\\\/et\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"et\",\"@id\":\"https:\\\/\\\/chemi-pharm.com\\\/et\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.chemi-pharm.com\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/Group-17-1.svg\",\"contentUrl\":\"https:\\\/\\\/www.chemi-pharm.com\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/Group-17-1.svg\",\"width\":282,\"height\":27,\"caption\":\"Chemi-Pharm\"},\"image\":{\"@id\":\"https:\\\/\\\/chemi-pharm.com\\\/et\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/chemipharmeesti\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/chemi-pharm.com\\\/et\\\/#\\\/schema\\\/person\\\/edf286ff172528816261c5720fe3fc91\",\"name\":\"Justin Hein\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"et\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/67ceecbee9650d8d85fa49c4a8c7be42fe7da584a8c835e3445413dd98e81b16?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/67ceecbee9650d8d85fa49c4a8c7be42fe7da584a8c835e3445413dd98e81b16?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/67ceecbee9650d8d85fa49c4a8c7be42fe7da584a8c835e3445413dd98e81b16?s=96&d=mm&r=g\",\"caption\":\"Justin Hein\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"E-veoselehe\u00a0liidestamise\u00a0toetus-programmi raames v\u00f5etakse kasutusele elektroonilised veodokumendid - Chemi-Pharm","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/chemi-pharm.com\/et\/e-veoselehe-liidestamise-toetusprogrammi-raames-voetakse-kasutusele-elektroonilised-veodokumendid\/","og_locale":"et_EE","og_type":"article","og_title":"E-veoselehe\u00a0liidestamise\u00a0toetus-programmi raames v\u00f5etakse kasutusele elektroonilised veodokumendid - Chemi-Pharm","og_description":"AS Chemi-Pharm v\u00f5tab e-veoselehe liidestamise toetusprogrammi raames kasutusele elektroonilised veodokumendid. Projekt viiakse ellu ajavahemikul 26.05.2025 – 30.09.2025. Euroopa Liidus hakkab 2027. aastal kehtima eFTI m\u00e4\u00e4rus, mis kohustab ettev\u00f5tteid kasutama elektroonilisi veodokumente. K\u00e4esoleva projekti elluviimisega tagab AS Chemi-Pharm eFTI m\u00e4\u00e4rusele vastavuse. Seejuures s\u00e4\u00e4stab e-veoselehe kasutuselev\u00f5tt ettev\u00f5ttes transpordi dokumentatsiooni koostamisele kuluvat aega, v\u00e4hendab vigu ning paberikulu ja sellega seotud CO\u2082 jalaj\u00e4lge. Projekti kogumaksumus […]","og_url":"https:\/\/chemi-pharm.com\/et\/e-veoselehe-liidestamise-toetusprogrammi-raames-voetakse-kasutusele-elektroonilised-veodokumendid\/","og_site_name":"Chemi-Pharm","article_publisher":"https:\/\/www.facebook.com\/chemipharmeesti","article_published_time":"2025-06-05T07:16:11+00:00","article_modified_time":"2025-06-05T07:16:37+00:00","og_image":[{"width":1200,"height":674,"url":"https:\/\/chemi-pharm.com\/wp-content\/uploads\/2025\/01\/nextgen_rahastanud_el_nextgeneration_eng_hor_color.jpg","type":"image\/jpeg"}],"author":"Justin Hein","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/chemi-pharm.com\/et\/e-veoselehe-liidestamise-toetusprogrammi-raames-voetakse-kasutusele-elektroonilised-veodokumendid\/#article","isPartOf":{"@id":"https:\/\/chemi-pharm.com\/et\/e-veoselehe-liidestamise-toetusprogrammi-raames-voetakse-kasutusele-elektroonilised-veodokumendid\/"},"author":{"name":"Justin Hein","@id":"https:\/\/chemi-pharm.com\/et\/#\/schema\/person\/edf286ff172528816261c5720fe3fc91"},"headline":"E-veoselehe\u00a0liidestamise\u00a0toetus-programmi raames v\u00f5etakse kasutusele elektroonilised veodokumendid","datePublished":"2025-06-05T07:16:11+00:00","dateModified":"2025-06-05T07:16:37+00:00","mainEntityOfPage":{"@id":"https:\/\/chemi-pharm.com\/et\/e-veoselehe-liidestamise-toetusprogrammi-raames-voetakse-kasutusele-elektroonilised-veodokumendid\/"},"wordCount":96,"publisher":{"@id":"https:\/\/chemi-pharm.com\/et\/#organization"},"image":{"@id":"https:\/\/chemi-pharm.com\/et\/e-veoselehe-liidestamise-toetusprogrammi-raames-voetakse-kasutusele-elektroonilised-veodokumendid\/#primaryimage"},"thumbnailUrl":"https:\/\/chemi-pharm.com\/wp-content\/uploads\/2025\/01\/nextgen_rahastanud_el_nextgeneration_eng_hor_color.jpg","keywords":["projekt","nextgenerationeu"],"articleSection":["Uudised eestikeelsed"],"inLanguage":"et"},{"@type":"WebPage","@id":"https:\/\/chemi-pharm.com\/et\/e-veoselehe-liidestamise-toetusprogrammi-raames-voetakse-kasutusele-elektroonilised-veodokumendid\/","url":"https:\/\/chemi-pharm.com\/et\/e-veoselehe-liidestamise-toetusprogrammi-raames-voetakse-kasutusele-elektroonilised-veodokumendid\/","name":"E-veoselehe\u00a0liidestamise\u00a0toetus-programmi raames v\u00f5etakse kasutusele elektroonilised veodokumendid - Chemi-Pharm","isPartOf":{"@id":"https:\/\/chemi-pharm.com\/et\/#website"},"primaryImageOfPage":{"@id":"https:\/\/chemi-pharm.com\/et\/e-veoselehe-liidestamise-toetusprogrammi-raames-voetakse-kasutusele-elektroonilised-veodokumendid\/#primaryimage"},"image":{"@id":"https:\/\/chemi-pharm.com\/et\/e-veoselehe-liidestamise-toetusprogrammi-raames-voetakse-kasutusele-elektroonilised-veodokumendid\/#primaryimage"},"thumbnailUrl":"https:\/\/chemi-pharm.com\/wp-content\/uploads\/2025\/01\/nextgen_rahastanud_el_nextgeneration_eng_hor_color.jpg","datePublished":"2025-06-05T07:16:11+00:00","dateModified":"2025-06-05T07:16:37+00:00","breadcrumb":{"@id":"https:\/\/chemi-pharm.com\/et\/e-veoselehe-liidestamise-toetusprogrammi-raames-voetakse-kasutusele-elektroonilised-veodokumendid\/#breadcrumb"},"inLanguage":"et","potentialAction":[{"@type":"ReadAction","target":["https:\/\/chemi-pharm.com\/et\/e-veoselehe-liidestamise-toetusprogrammi-raames-voetakse-kasutusele-elektroonilised-veodokumendid\/"]}]},{"@type":"ImageObject","inLanguage":"et","@id":"https:\/\/chemi-pharm.com\/et\/e-veoselehe-liidestamise-toetusprogrammi-raames-voetakse-kasutusele-elektroonilised-veodokumendid\/#primaryimage","url":"https:\/\/chemi-pharm.com\/wp-content\/uploads\/2025\/01\/nextgen_rahastanud_el_nextgeneration_eng_hor_color.jpg","contentUrl":"https:\/\/chemi-pharm.com\/wp-content\/uploads\/2025\/01\/nextgen_rahastanud_el_nextgeneration_eng_hor_color.jpg","width":1200,"height":674},{"@type":"BreadcrumbList","@id":"https:\/\/chemi-pharm.com\/et\/e-veoselehe-liidestamise-toetusprogrammi-raames-voetakse-kasutusele-elektroonilised-veodokumendid\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/chemi-pharm.com\/et\/"},{"@type":"ListItem","position":2,"name":"E-veoselehe\u00a0liidestamise\u00a0toetus-programmi raames v\u00f5etakse kasutusele elektroonilised veodokumendid"}]},{"@type":"WebSite","@id":"https:\/\/chemi-pharm.com\/et\/#website","url":"https:\/\/chemi-pharm.com\/et\/","name":"Chemi-Pharm","description":"Chemi-Pharm'i professionaalsed ja k\u00f5rge kvaliteediga desinfektsiooni- ja puhastusvahendid otse tootjalt","publisher":{"@id":"https:\/\/chemi-pharm.com\/et\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/chemi-pharm.com\/et\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"et"},{"@type":"Organization","@id":"https:\/\/chemi-pharm.com\/et\/#organization","name":"Chemi-Pharm","url":"https:\/\/chemi-pharm.com\/et\/","logo":{"@type":"ImageObject","inLanguage":"et","@id":"https:\/\/chemi-pharm.com\/et\/#\/schema\/logo\/image\/","url":"https:\/\/www.chemi-pharm.com\/wp-content\/uploads\/2021\/03\/Group-17-1.svg","contentUrl":"https:\/\/www.chemi-pharm.com\/wp-content\/uploads\/2021\/03\/Group-17-1.svg","width":282,"height":27,"caption":"Chemi-Pharm"},"image":{"@id":"https:\/\/chemi-pharm.com\/et\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/chemipharmeesti"]},{"@type":"Person","@id":"https:\/\/chemi-pharm.com\/et\/#\/schema\/person\/edf286ff172528816261c5720fe3fc91","name":"Justin Hein","image":{"@type":"ImageObject","inLanguage":"et","@id":"https:\/\/secure.gravatar.com\/avatar\/67ceecbee9650d8d85fa49c4a8c7be42fe7da584a8c835e3445413dd98e81b16?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/67ceecbee9650d8d85fa49c4a8c7be42fe7da584a8c835e3445413dd98e81b16?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/67ceecbee9650d8d85fa49c4a8c7be42fe7da584a8c835e3445413dd98e81b16?s=96&d=mm&r=g","caption":"Justin Hein"}}]}},"author_meta":{"display_name":"Justin Hein","author_link":"https:\/\/chemi-pharm.com\/et\/author\/justin\/"},"featured_img":"https:\/\/chemi-pharm.com\/wp-content\/uploads\/2025\/01\/nextgen_rahastanud_el_nextgeneration_eng_hor_color-300x169.jpg","uagb_featured_image_src":{"full":["https:\/\/chemi-pharm.com\/wp-content\/uploads\/2025\/01\/nextgen_rahastanud_el_nextgeneration_eng_hor_color.jpg",1200,674,false],"thumbnail":["https:\/\/chemi-pharm.com\/wp-content\/uploads\/2025\/01\/nextgen_rahastanud_el_nextgeneration_eng_hor_color-150x150.jpg",150,150,true],"medium":["https:\/\/chemi-pharm.com\/wp-content\/uploads\/2025\/01\/nextgen_rahastanud_el_nextgeneration_eng_hor_color-300x169.jpg",300,169,true],"medium_large":["https:\/\/chemi-pharm.com\/wp-content\/uploads\/2025\/01\/nextgen_rahastanud_el_nextgeneration_eng_hor_color-768x431.jpg",768,431,true],"large":["https:\/\/chemi-pharm.com\/wp-content\/uploads\/2025\/01\/nextgen_rahastanud_el_nextgeneration_eng_hor_color-1024x575.jpg",1024,575,true],"1536x1536":["https:\/\/chemi-pharm.com\/wp-content\/uploads\/2025\/01\/nextgen_rahastanud_el_nextgeneration_eng_hor_color.jpg",1200,674,false],"2048x2048":["https:\/\/chemi-pharm.com\/wp-content\/uploads\/2025\/01\/nextgen_rahastanud_el_nextgeneration_eng_hor_color.jpg",1200,674,false],"news_thumb":["https:\/\/chemi-pharm.com\/wp-content\/uploads\/2025\/01\/nextgen_rahastanud_el_nextgeneration_eng_hor_color-600x337.jpg",600,337,true],"custom_thumb":["https:\/\/chemi-pharm.com\/wp-content\/uploads\/2025\/01\/nextgen_rahastanud_el_nextgeneration_eng_hor_color-200x112.jpg",200,112,true]},"uagb_author_info":{"display_name":"Justin Hein","author_link":"https:\/\/chemi-pharm.com\/et\/author\/justin\/"},"uagb_comment_info":0,"uagb_excerpt":"AS Chemi-Pharm v\u00f5tab e-veoselehe liidestamise toetusprogrammi raames kasutusele elektroonilised veodokumendid. Projekt viiakse ellu ajavahemikul 26.05.2025 – 30.09.2025. Euroopa Liidus hakkab 2027. aastal kehtima eFTI m\u00e4\u00e4rus, mis kohustab ettev\u00f5tteid kasutama elektroonilisi veodokumente. K\u00e4esoleva projekti elluviimisega tagab AS Chemi-Pharm eFTI m\u00e4\u00e4rusele vastavuse. Seejuures s\u00e4\u00e4stab e-veoselehe kasutuselev\u00f5tt ettev\u00f5ttes transpordi dokumentatsiooni koostamisele kuluvat aega, v\u00e4hendab vigu ning paberikulu ja sellega seotud CO\u2082 jalaj\u00e4lge. Projekti kogumaksumus…","coauthors":[],"tax_additional":{"categories":{"linked":["<a href=\"https:\/\/chemi-pharm.com\/et\/category\/uudised-est\/\" class=\"advgb-post-tax-term\">Uudised eestikeelsed<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Uudised eestikeelsed<\/span>"]},"tags":{"linked":["<a href=\"https:\/\/chemi-pharm.com\/et\/category\/uudised-est\/\" class=\"advgb-post-tax-term\">projekt<\/a>","<a href=\"https:\/\/chemi-pharm.com\/et\/category\/uudised-est\/\" class=\"advgb-post-tax-term\">nextgenerationeu<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">projekt<\/span>","<span class=\"advgb-post-tax-term\">nextgenerationeu<\/span>"]}},"comment_count":"0","relative_dates":{"created":"Posted 11 kuud ago","modified":"Updated 11 kuud ago"},"absolute_dates":{"created":"Posted on 05\/06\/2025","modified":"Updated on 05\/06\/2025"},"absolute_dates_time":{"created":"Posted on 05\/06\/2025 10:16","modified":"Updated on 05\/06\/2025 10:16"},"featured_img_caption":"","series_order":"","_links":{"self":[{"href":"https:\/\/chemi-pharm.com\/et\/wp-json\/wp\/v2\/posts\/8205","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/chemi-pharm.com\/et\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/chemi-pharm.com\/et\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/chemi-pharm.com\/et\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/chemi-pharm.com\/et\/wp-json\/wp\/v2\/comments?post=8205"}],"version-history":[{"count":2,"href":"https:\/\/chemi-pharm.com\/et\/wp-json\/wp\/v2\/posts\/8205\/revisions"}],"predecessor-version":[{"id":8207,"href":"https:\/\/chemi-pharm.com\/et\/wp-json\/wp\/v2\/posts\/8205\/revisions\/8207"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/chemi-pharm.com\/et\/wp-json\/wp\/v2\/media\/7712"}],"wp:attachment":[{"href":"https:\/\/chemi-pharm.com\/et\/wp-json\/wp\/v2\/media?parent=8205"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/chemi-pharm.com\/et\/wp-json\/wp\/v2\/categories?post=8205"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/chemi-pharm.com\/et\/wp-json\/wp\/v2\/tags?post=8205"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}